Skip to main content

US ClosedU.S. Closed

SPRY: ARS Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology.

52W Range

12thpctl

Volume

0.62×avg

Market Cap

584.90MUSD

P/E Ratio

-2.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

ARS Pharmaceuticals, Inc.

SPRYNASDAQ Global Market·USD·Closed

ARS Pharmaceuticals, Inc.

SPRYNASDAQ·USD·Closed

$5.89

−2.32%

$5.89

−$0.14 (2.32%)

52W Range

12thpctl

Volume

0.62×avg

Mkt Cap

584.90MUSD

P/E

-2.7TTM

Div Yield

–ann